{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:27:21Z","timestamp":1787772441835,"version":"build-2784847793"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:sec>\n                    <jats:title>PURPOSE:<\/jats:title>\n                    <jats:p>The purpose of this study was to analyze the clinical profile of patients with scleritis managed by a single ophthalmologist in a tertiary eye care center.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>This was a retrospective analysis of 107 eyes of 96 patients with scleritis from January 2007 to December 2018.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>Female predominance (68%) with a relatively young-onset (46 \u00b1 14 years) of scleritis was observed. Diffuse anterior scleritis (41%) was the most common subtype of scleritis, and the most common systemic association was rheumatoid arthritis (18%). Three-fourth of patients received immunosuppressive treatment (74%) along with corticosteroids. The mean follow-up period was 3 \u00b1 2.5 (range: 0.6\u201310) years. Necrotizing scleritis was at a 3.5 times higher risk of developing ocular complications. Eighty percent of patients maintained the same vision. Recurrence of scleritis was noted in 25 eyes (23%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>Diffuse scleritis is the most common scleritis in our population. Tuberculosis was commonly seen with diffuse scleritis. The likelihood of developing ocular complications (cataract and glaucoma) was higher in necrotizing scleritis, thus requiring periodic monitorization.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ojo.ojo_168_21","type":"journal-article","created":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T13:51:33Z","timestamp":1716558693000},"page":"153-158","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Clinical profile, treatment, and visual outcome of scleritis"],"prefix":"10.4103","volume":"15","author":[{"given":"Kowsigan","family":"Magesan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gazal","family":"Patnaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parthopratim Dutta","family":"Majumder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyotirmay","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-7-20240908","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.survophthal.2005.04.001","article-title":"Scleritis","volume":"50","author":"Okhravi","year":"2005","journal-title":"Surv Ophthalmol"},{"key":"R3-7-20240908","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/bjo.60.3.163","article-title":"Scleritis and episcleritis","volume":"60","author":"Watson","year":"1976","journal-title":"Br J Ophthalmol"},{"key":"R4-7-20240908","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0161-6420(94)31325-X","article-title":"Severity of scleritis and episcleritis","volume":"101","author":"Sainz de la Maza","year":"1994","journal-title":"Ophthalmology"},{"key":"R5-7-20240908","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1136\/bjo.2009.171744","article-title":"Clinical features and visual outcomes of Japanese patients with scleritis","volume":"94","author":"Keino","year":"2010","journal-title":"Br J Ophthalmol"},{"key":"R6-7-20240908","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1136\/bjo.60.3.192","article-title":"Episcleritis and scleritis. A study of their clinical manifestation and association with rheumatoid arthritis","volume":"60","author":"McGavin","year":"1976","journal-title":"Br J Ophthalmol"},{"key":"R7-7-20240908","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0002-9394(00)00710-8","article-title":"Episcleritis and scleritis: Clinical features and treatment results","volume":"130","author":"Jabs","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"R8-7-20240908","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ophtha.2011.07.013","article-title":"Clinical characteristics of a large cohort of patients with scleritis and episcleritis","volume":"119","author":"Sainz de la Maza","year":"2012","journal-title":"Ophthalmology"},{"key":"R9-7-20240908","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/ICO.0b013e3181ac9fad","article-title":"Clinical features, prognosis, and treatment results of patients with scleritis from 2 tertiary eye care centers in Turkey","volume":"29","author":"Erkanli","year":"2010","journal-title":"Cornea"},{"key":"R10-7-20240908","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.4103\/ijo.IJO_777_18","article-title":"Antineutrophil cytoplasmic antibody-positive scleritis: Clinical profile of patients from a tuberculosis-endemic region","volume":"66","author":"Majumder","year":"2018","journal-title":"Indian J Ophthalmol"},{"key":"R11-7-20240908","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1080\/09273948.2016.1223857","article-title":"Clinical profile of patients with necrotizing scleritis in a tertiary eye care center in Southern India","volume":"26","author":"Dutta Majumder","year":"2018","journal-title":"Ocul Immunol Inflamm"},{"key":"R12-7-20240908","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.4103\/ijo.IJO_121_18","article-title":"Clinical profile of patients with posterior scleritis: A report from Eastern India","volume":"66","author":"Kumar","year":"2018","journal-title":"Indian J Ophthalmol"},{"key":"R13-7-20240908","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.4103\/ijo.IJO_2154_19","article-title":"Clinical profile of patients with anterior nodular scleritis in India","volume":"68","author":"Patnaik","year":"2020","journal-title":"Indian J Ophthalmol"},{"key":"R14-7-20240908","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s10384-018-0600-y","article-title":"Clinical characteristics and ocular complications of patients with scleritis in Japanese","volume":"62","author":"Tanaka","year":"2018","journal-title":"Jpn J Ophthalmol"},{"key":"R15-7-20240908","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1080\/09273948.2020.1716026","article-title":"Clinical profile of patients with scleritis in Bangladesh","volume":"29","author":"Rahman","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"key":"R16-7-20240908","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/09273948.2019.1574838","article-title":"Clinical features, treatment, and visual outcomes of Japanese patients with posterior scleritis","volume":"28","author":"Ando","year":"2020","journal-title":"Ocul Immunol Inflamm"},{"key":"R17-7-20240908","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/09273948.2016.1241282","article-title":"Clinical features and complications of scleritis in Chinese patients","volume":"26","author":"Yang","year":"2018","journal-title":"Ocul Immunol Inflamm"},{"key":"R18-7-20240908","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1080\/09273948.2018.1484496","article-title":"Clinical features of scleritis across the Asia-Pacific region","volume":"27","author":"Lane","year":"2019","journal-title":"Ocul Immunol Inflamm"},{"key":"R19-7-20240908","first-page":"1215","article-title":"Clinical features and visual outcomes of scleritis patients presented to tertiary care eye centers in Saudi Arabia","volume":"8","author":"Al Barqi","year":"2015","journal-title":"Int J Ophthalmol"},{"key":"R20-7-20240908","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3109\/09273948.2015.1005240","article-title":"Posterior scleritis: Analysis of epidemiology, clinical factors, and risk of recurrence in a cohort of 114 patients","volume":"24","author":"Lavric","year":"2016","journal-title":"Ocul Immunol Inflamm"},{"key":"R21-7-20240908","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0161-6420(91)32269-3","article-title":"Progression of scleral disease","volume":"98","author":"Tuft","year":"1991","journal-title":"Ophthalmology"},{"key":"R22-7-20240908","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ophtha.2012.08.005","article-title":"Visual outcome, treatment results, and prognostic factors in patients with scleritis","volume":"120","author":"Wieringa","year":"2013","journal-title":"Ophthalmology"},{"key":"R23-7-20240908","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1016\/S0161-6420(99)90543-2","article-title":"Posterior scleritis: Clinical features, systemic associations, and outcome in a large series of patients","volume":"106","author":"McCluskey","year":"1999","journal-title":"Ophthalmology"},{"key":"R24-7-20240908","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ajo.2009.09.026","article-title":"Mycophenolate mofetil for ocular inflammation","volume":"149","author":"Daniel","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"R25-7-20240908","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3109\/09273948.2012.655398","article-title":"Mycophenolate mofetil in the treatment of chronic non-infectious, non-necrotizing scleritis","volume":"20","author":"Kolomeyer","year":"2012","journal-title":"Ocul Immunol Inflamm"}],"container-title":["Oman Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ojo.ojo_168_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:47:08Z","timestamp":1787770028000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ojo.ojo_168_21"}},"subtitle":["A single ophthalmologist experience"],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/ojo.ojo_168_21","relation":{},"ISSN":["0974-620X"],"issn-type":[{"value":"0974-620X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]}}}